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Purpose: Papillary thyroid cancer with level VII (anterior superior mediastinal lymph nodes) lymph node metastasis belongs 
to Stage IV a according to the Americal Joint Committee on Cancer cancer staging. The aim of our study was to identify clin-
icopathologic factors that are related to level VII cervical lymph node metastasis and to suggest recommendations for level 
VII dissection. Methods: We reviewed 195 patients with papillary thyroid carcinoma who had their initial operation contain-
ing level VII dissection from April 2006 to June 2007. Level VII dissection involved lymph nodes in the anterior superior me-
diastinum and tracheoesophageal grooves, extending from the suprasternal notch to the innominate artery. Clinicophatho-
logic factors, such as gender, age and lateral neck metastasis, related to Level VII metastasis were analyzed by tumor size, 
multifocality of tumor, extrathyroidal extension and lymphovascular invasion. Results: Nine (4.6%) of 195 patients with pap-
illary thyroid carcinoma had level VII metastasis. Clinicopathologic factors that were related to level VII metastasis included 
lateral neck metastasis (P ＜ 0.01), tumor size (P ＜ 0.01) and lymphovascular invasion (P ＜ 0.05). Conclusion: If pre-
operatively, the tumor size is over 1.5 cm, or there is lateral neck metastasis, level VII dissection must be considered. If there 
is lymphovascular invasion pathologic findings postoperatively, special attention should be paid for detection of level VII 
recurrence.
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INTRODUCTION
Significant controversy exists with respect to the prog-
nostic significance of lymph node metastasis (LNM) in 
papillary thyroid carcinoma (PTC). Although several 
studies have shown that the presence of LNM has no im-
pact on survival [1-4], previous studies by Mazzaferri and 
Jhiang [5], Scheumann et al. [6], Hughes et al. [7], and 
Lundgren et al. [8] have demonstrated that LNM is an de-
pendent predictor of cancer mortality. The N category of 
TNM stage for PTC according to the American Joint 
Committee on Cancer (AJCC) cancer staging manual 6th 
edition (2002) are described as follow: first echelon 
(central compartment/level VI) or N1a, and lateral cervical 
and/or superior mediastinal or N1b [9]. Level VII (anterior 
superior mediastinal lymph nodes) LNM particularly be-Jae-Young Choi, et al.
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Fig. 1. Anatomical boundaries of nodal levels VI (central 
compartment group) and Vll (superior mediastinal group) (re-
printed from Shah JP, Patel SG. Head and neck surgery and 
oncology. 3rd ed. London: Mosby; 2002. p.355, with permission of 
Elsevier.)  [10].
Fig. 2. The surgical field following 
level Vll dissection. (A) The right 
innominate artery was dissected 
free from the level Vll lymph nodes. 
(B) The left innominate vein was 
dissected from the level Vll lymph 
nodes and the left common carotid 
artery was retracted laterally with a 
long-arm retractor. 
longs to Stage IVa. The manual defines level VII as lymph 
nodes in the anterior superior mediastinum and the tra-
cheoesophageal grooves, extending from the suprasternal 
notch to the innominate artery (Fig. 1) [10]. Because level 
VII LNM is consider to be an important factor for determi-
nation of cancer staging and prediction of prognoses, we 
attempted to identify clinicopathologic factors that are re-
lated to level VII LNM and then to suggest recom-
mendations for level VII dissection.
METHODS
Patients
We reviewed 195 patients with PTC who had an initial 
operation containing level VII dissection from April 2006 
to June 2007. There were 30 males and 165 females. The 
mean patient age was 47.7 years (range, 25 to 74 years). 
Thyroid lobectomy with central compartment neck dis-
section (CCND) was performed on 36 patients, total or 
near total thyroidectomy with CCND on 144 patients, and 
total thyroidectomy with CCND and modified radical 
neck dissection on 15 patients.  
Methods of level VII dissection
Level VII dissection is very difficult if the sternum is not 
opened, but we attempted to perform level VII dissection 
without opening the sternum. We preferentially dissected 
anterior superior mediastinal lymph nodes above the in-
nominate artery and vein. After retracting the innominate 
vessel and the trachea with a Sofield Retractor (long-arm 
retractor, Medicon Co., Seoul, Korea), we were able to dis-
sect lymph nodes in the tracheoesophageal grooves, ex-
tending from the suprasternal notch to the innominate ar-
tery (Fig. 2). This technique allowed for level VII dissection Dissect level Vll cervical lymph node 
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Fig. 3. (A) Right thyroid lobectomy, 
along with level Vl and Vll dis-
section was performed as en bloc 
dissection.  (B) We separated level 
Vll lymph nodes from thyroid and 
level Vl lymph nodes after resection.
Table 1. Patients’demographics
                      Variable  Value
Gender
　Male   30 (15)
   Female 165 (85)
Age
  ＜45 yr   82 (42)    
  ≥45 yr 113 (58) 
Extrathyroidal extension
   Present   66 (34)
   Absent 129 (66)
Tumor size  
  ＜1.5 cm 163 (84)        
  ≥1.5 cm   32 (16)  
Lateral neck metastasis
   Present 15 (8)    
   Absent  180 (92)   
Multifocality
   Single 138 (71)     
   Multifocal   57 (29) 
Lymphovascular invasion
   Present   56 (29)  
   Absent 139 (71)
Values are presented as no. of patients (%).
without opening the sternum. Thyroidectomy along with 
level VI and VII dissection was performed as en bloc dis-
section, and then level VII lymph nodes were separated 
from the thyroid and level VI lymph nodes (Fig. 3).
Clinicopathologic factors for analysis
Clinicophathologic factors that were to be analyzed in 
this study level VII LNM were gender, age, lateral neck 
metastasis, tumor size, tumor multifocality, extrathy-
roidal extension and lymphovascular invasion.
Statistical analysis
Statistical analyses were performed using SPSS ver. 12.0 
(SPSS Inc., Chicago, IL, USA). Comparisons of differences 
were made with the chi-square test. A P-value of less than 
0.05 was considered significant.
RESULTS
Of 195 patients with PTC who had an initial operation 
involving level VII dissection, 88 (45.1%) showed meta-
stasis to the central compartment, and mean number of 
dissected central lymph nodes was 12.9, and the mean tu-
mor size was 11.1 mm. Sixty-six patients (33.8%) had extra-
thyroidal extension, and 57 patients (29.2%) had tumor 
multifolcality. Fifty-six patients (28.7%) showed lympho-Jae-Young Choi, et al.
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Table 2. Relationships between gender, age, multifocality, 
extrathyroidal extension and level Vll lymph node metastasis
Variable Absent Present P-value
Gender NS
　Male  30 0 (0)
    Female 165   9 (5.5)
Age NS
    ＜45 yr  82   1 (1.2)
    ≥45 yr 113   8 (7.1)
Multifocality NS
    Single 138   4 (2.9)
    Multifocal  57   5 (8.8)
Extrathyroidal extension NS
    Present  66   5 (7.6)
    Absent 129   4 (3.1)
Values are presented as no. of patients with level Vll cervical 
lymph node metastasis (%). 
NS, not significant.
Table 3. Relationships between lateral neck metastasis, tumor size, 
lymphovascular invasion and level Vll lymph node metastasis
Variable Absent Present P-value
Lateral neck metastasis ＜0.01
   Present   15    4 (26.7)
   Absent 180   5 (2.8)
Tumor size ＜0.01
   ＜1.5 cm 163   4 (2.5)
   ≥1.5 cm   32     5 (15.6)
Lymphovascular invasion ＜0.05
    Present   56    6 (10.7) 
    Absent 139 3 (2.2)
Values are presented as no. of patients with level Vll cervical 
lymph node metastasis (%).
vascular invasion (Table 1).
Nine patients (4.6%) showed level VII LNM, and we an-
alyzed clinicophathologic factors related to level VII 
LNM. Table 2 shows relationships between gender, age, 
multifocality, extrathyroidal extension and level VII LNM. 
All patients with level VII LNM were females. The level 
VII LNM rate was 1.2% for patients aged ＜45 years and 
7.1% for those aged ≥45 years. Five patients (8.8%) with 
multifocal tumor had level VII LNM. The level VII LNM 
rate was 7.6% for tumors presenting extrathyroidal ex-
tension and 3.1% for those whose tumors did not present 
extrathyroidal extension. All factors in Table 2 were not 
significantly related to level VII LNM. 
Fifteen patients had lateral neck metastasis, and 4 
(26.7%) of the 15 patients had level VII LNM. Of the 180 pa-
tients who did not have lateral neck metastasis, 5 (2.8%) 
had level VII LNM (P ＜  0.01). The level VII LNM rate was 
2.5% for tumors measuring ＜1.5 cm, 15.6% for those 
measuring ≥1.5 cm (P ＜ 0.01) (Table 3). The level VII 
LNM rate was 10.7% for tumors presenting lymphovas-
cular invasion and 2.2% for those whose tumors did not 
present lymphovascular invasion (P ＜  0.05) (Table 3). The 
level VII LNM rate was significantly elevated when there 
was lateral neck metastasis, tumor size ＞1.5 cm or lym-
phovascular invasion. 
Complication after level VII LN dissection is that 5 pa-
tients (2.6%) had chyle leakage, 4 patients (2%) had right 
pleural injury, and 1 patient had left innominate vein 
injury. Four patients (2%) displayed permanent hypopar-
athyroidism, and 2 patients (1%) displayed unintentional 
permanent nerve injuries.
DISCUSSION
It has been generally recognized that surgical resection 
is the most effective treatment modality for thyroid 
carcinoma. However, the optimal treatment for differ-
entiated thyroid carcinoma controversial with respect to 
the extent of thyroid resection, extent and technique of no-
dal dissection, and use of prophylactic radioiodine ther-
apy [11,12]. Several studies have defined different prog-
nostic factors and treatment strategies for papillary thy-
roid carcinoma [1,3,5]. Central and lateral compartments 
are representative of regional lymph nodes related to thy-
roid carcinoma. Since the central compartment can be dis-
sected through the same incision as thyroidectomy, these 
nodes have been routinely dissected by most endocrine 
surgeons. A standardized classification system for neck 
dissection was published in 1991 [13] with a recent update 
in 2002 [14]. This neck dissection classification did not rec-
ommend inclusion of additional levels such as level VII for 
the superior mediastinum. It is believed that the 6 levels in 
current use encompass the complete topographic anat-
omy of the neck. Level VII is considered to be a specific no-
dal group. However, according to the AJCC cancer stag-Dissect level Vll cervical lymph node 
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ing, level VII (anterior superior mediastinal lymph nodes) 
LNM belongs to Stage IVa [9], which means that level VII 
LNM influences mortality due to PTC. Thus, it is not right 
that level VII belongs to a specific group, and we should 
know how many patients with PTC have level VII LNM. 
Level VII lymph nodes are defined as lymph nodes in the 
anterior superior mediastinum and the tracheoesophag-
eal grooves, extending from the suprasternal notch to the 
innominate artery [10]. Level VII nodes have been rou-
tinely dissected by most endocrine surgeons, and it has 
been recognized that level VII dissection is difficult to per-
form through the same incision as thyroidectomy. Despite 
the aforementioned results, we were able to dissect level 
VII lymph nodes through the same incision after retract-
ing the innominate vessel and the trachea with a Sofield 
Retractor (Medicon Co.) (Fig. 3).
There have been some reports on relations between clin-
icopathologic factors and LNM. Goropoulos et al. [15] 
have reported that there is a significant correlation be-
tween multicentric tumor and LNM. Hay et al. [16] and 
Scheumann et al. [6] have reported that there is a sig-
nificant correlation between tumor size and LNM.
There have been few reports on correlations between 
clinicopathologic factors and level VII LNM. In this study, 
we attempted to investigate the feasibility of level VII dis-
section without opening the sternum rather than the ef-
fects of level VII dissection on survival or recurrence in 
PTC. According to our study, the level VII LNM rate was 
significantly elevated in patients with lateral neck meta-
stasis, or those with a tumor size ＞1.5 cm or lymphovas-
cular invasion. Thus, level VII dissection should be consid-
ered in patients with lateral neck metestasis or those with 
a tumor size of ＞1.5 cm. If histopathological examination 
of surgical specimens reveals that there is lymphovascular 
invasion, special attention should be paid to the detection 
of level VII recurrence. 
It is thought that there may be a higher rate of perma-
nent hypoparathyroidism, unintentional permanent 
nerve injury, chyle leakage, pleural injury and vessel in-
jury when level VII LN dissection is performed than for 
level VI LN dissection alone. But our study is similar other 
large data [17]. If closed attentional operation is per-
formed, complication is due to level VII LN dissection is 
not higher rate than level VI LN dissection alone.
Further studies on the rates of mortality and recurrence 
are needed to confirm our results.
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